Abstract
Significant strides have been made in mammalian cell based biopharmaceutical process and cell line development over the past years. With several established mammalian host cell lines and expression systems, optimization of selection systems to reduce development times and improvement of glycosylation patterns are only some of the advances being made to improve cell culture processes. In this article, the advances pertaining to cell line development and cell engineering strategies are discussed. An overview of the cell engineering strategies to enhance cellular characteristics by genetic manipulation are illustrated, focusing on the use of genomics and proteomics tools and their application in such endeavors. Included in this review are some of the early studies using the ‘omic’ technique to understand cellular mechanisms of product synthesis and secretion, apoptosis, cell proliferation and the influence of the physicochemical environment. The article highlights the significance of integrating genomics and proteomics data with the vast amounts of bioprocess data for improved analysis of the biological pathways involved. Further improvements of the techniques and methodologies used are needed but ultimately, the new cell engineering strategies should provide great insight into the regulatory networks within the cell in a bioprocess environment and how to manipulate them to increase overall productivity.
Similar content being viewed by others
References
Aebersold R, Mann M (2003) Mass spectrometry-based proteomics. Nature 422:198–207
Al-Rubeai M (1998) Apoptosis and cell culture technology. Adv Biochem Eng Biotechnol 59:225–249
Al-Rubeai M, Singh RP (1998) Apoptosis in cell culture. Curr Opin Biotechnol 9:152–156
Alete DE, Racher AJ, Birch JR, Stansfield SH, James DC, Smales CM (2005) Proteomic analysis of enriched microsomal fractions from GS-NS0 murine myeloma cells with varying secreted recombinant monoclonal antibody productivities. Proteomics 5:4689–4704
Antoniou M, Harland L, Mustoe T, Williams S, Holdstock J, Yague E, Mulcahy T, Griffiths M, Edwards S, Ioannou PA, Mountain A, Crombie R (2003) Transgenes encompassing dual-promoter CpG islands from the human TBP and HNRPA2B1 loci are resistant to heterochromatin-mediated silencing. Genomics 82:269–279
Baer A, Bode J (2001) Coping with kinetic and thermodynamic barriers: RMCE, an efficient strategy for the targeted integration of transgenes. Curr Opin Biotechnol 12:473–480
Baik JY, Lee MS, An SR, Yoon SK, Joo EJ, Kim YH, Park HW, Lee GM (2006) Initial transcriptome and proteome analyses of low culture temperature-induced expression in CHO cells producing erythropoietin. Biotechnol Bioeng 93:361–371
Bailey JE, Sburlati A, Hatzimanikatis V, Lee K, Renner WA, Tsai PS (2002) Inverse metabolic engineering: a strategy for directed genetic engineering of useful phenotypes. Biotechnol Bioeng 79:568–579
Baker KN, Rendall MH, Hills AE, Hoare M, Freedman RB, James DC (2001) Metabolic control of recombinant protein N-glycan processing in NS0 and CHO cells. Biotechnol Bioeng 73:188–202
Baldi L, Muller N, Picasso S, Jacquet R, Girard P, Thanh HP, Derow E, Wurm FM (2005) Transient gene expression in suspension HEK-293 cells: application to large-scale protein production. Biotechnol Prog 21:148–153
Barnes LM, Bentley CM, Dickson AJ (2001) Characterization of the stability of recombinant protein production in the GS-NS0 expression system. Biotechnol Bioeng 73:261–270
Barnes LM, Bentley CM, Dickson AJ (2003) Stability of protein production from recombinant mammalian cells. Biotechnol Bioeng 81:631–639
Barnes LM, Bentley CM, Dickson AJ (2004) Molecular definition of predictive indicators of stable protein expression in recombinant NS0 myeloma cells. Biotechnol Bioeng 85:115–121
Barnes LM, Dickson AJ (2006) Mammalian cell factories for efficient and stable protein expression. Curr Opin Biotechnol 17:381–386
Barnes LM, Bentley CM, Dickson AJ (2000) Advances in animal cell recombinant protein production: GS-NS0 expression system. Cytotechnology 32:109–123
Bebbington CR, Renner G, Thomson S, King D, Abrams D, Yarranton GT (1992) High-level expression of a recombinant antibody from myeloma cells using a glutamine synthetase gene as an amplifiable selectable marker. Biotechnology (NY) 10:169–175
Bentwich I, Avniel A, Karov Y, Aharonov R, Gilad S, Barad O, Barzilai A, Einat P, Einav U, Meiri E, Sharon E, Spector Y, Bentwich Z (2005) Identification of hundreds of conserved and nonconserved human microRNAs. Nat Genet 37:766–770
Bi JX, Shuttleworth J, Al-Rubeai M (2004) Uncoupling of cell growth and proliferation results in enhancement of productivity in p21CIP1-arrested CHO cells. Biotechnol Bioeng 85:741–749
Böhm E, Voglauer R, Steinfellner W, Kunert R, Borth N, Katinger H (2004) Screening for improved cell performance: selection of subclones with altered production kinetics or improved stability by cell sorting. Biotechnol Bioeng 88:699–706
Borth N, Zeyda M, Kunert R, Katinger H (2000) Efficient selection of high-producing subclones during gene amplification of recombinant Chinese hamster ovary cells by flow cytometry and cell sorting. Biotechnol Bioeng 71:266–273
Brewer JW, Hendershot LM (2005) Building an antibody factory: a job for the unfolded protein response. Nat Immunol 6:23–29
Brummelkamp TR, Bernards R, Agami R (2002) A system for stable expression of short interfering RNAs in mammalian cells. Science 296:550–553
Butler M (2005) Animal cell cultures: recent achievements and perspectives in the production of biopharmaceuticals. Appl Microbiol Biotechnol 68:283–291
Carroll S, Al-Rubeai M (2004) The selection of high-producing cell lines using flow cytometry and cell sorting. Expert Opin Biol Ther 4:1821–1829
Carroll S, Al-Rubeai M (2005) ACSD labelling and magnetic cell separation: a rapid method of separating antibody secreting cells from non-secreting cells. Journal of Immunological Methods 296:171–178
Carvalhal AV, Marcelino I, Carrondo MJ (2003) Metabolic changes during cell growth inhibition by p 27 overexpression. Appl Microbiol Biotechnol 63:164–173
Carvalhal AV, Moreira JL, Carrondo MJ (2001) Strategies to modulate BHK cell proliferation by the regulation of IRF-1 expression. J Biotechnol 92:47–59
Champion KM, Arnott D, Henzel WJ, Hermes S, Weikert S, Stults J, Vanderlaan M, Krummen L (1999) A two-dimensional protein map of Chinese hamster ovary cells. Electrophoresis 20:994–1000
Chan E (2006) Integrating Transcriptomics and Proteomics. Genomics and Proteomics [April 2006]. 1-4-2006. Advantage Media. Ref Type: Magazine Article
Charbonneau JR, Furtak T, Lefebvre J, Gauthier ER (2003) Bcl-xL expression interferes with the effects of L-glutamine supplementation on hybridoma cultures. Biotechnol Bioeng 81:279–290
Chee Furng WD, Tin Kam WK, Tang GL, Kiat HC, Gek Sim YM (2005) Impact of dynamic online fed-batch strategies on metabolism, productivity and N-glycosylation quality in CHO cell cultures. Biotechnol Bioeng 89:164–177
Cheng AM, Byrom MW, Shelton J, Ford LP (2005) Antisense inhibition of human miRNAs and indications for an involvement of miRNA in cell growth and apoptosis. Nucleic Acids Res 33:1290–1297
Chun BH, Park SY, Chung N, Bang WG (2003) Enhanced production of recombinant B-domain deleted factor VIII from Chinese hamster ovary cells by propionic and butyric acids. Biotechnol Lett 25:315–319
Chung JD, Sinskey AJ, Stephanopoulos G (1998) Growth factor and bcl-2 mediated survival during abortive proliferation of hybridoma cell line. Biotechnol Bioeng 57:164–171
Cockett MI, Bebbington CR, Yarranton GT (1990) High level expression of tissue inhibitor of metalloproteinases in Chinese hamster ovary cells using glutamine synthetase gene amplification. Biotechnology (NY) 8:662–667
Cotter TG, Al-Rubeai M (1995) Cell death (apoptosis) in cell culture systems. Trends Biotechnol 13:150–155
Crea F, Al-Rubeai M (2006) Does Telomerase Over-Expression Enhance Chromosomal Stability and Possibly Production Stability. Unpublished results
Crea F, Sarti D, Faleiani F, Al-Rubeai M (2006) Over-expression of hTERT in CHO KI results in decreased apoptosis and reduced serum dependency. J Biotechnol 121:109–123
Crommelin DJ, Storm G, Verrijk R, de LL, Jiskoot W, Hennink WE (2003) Shifting paradigms: biopharmaceuticals versus low molecular weight drugs. Int J Pharm 266:3–16
Davie JR (2003) Inhibition of histone deacetylase activity by butyrate. J Nutr 133:2485S-2493S
Davies J, Jiang L, Pan LZ, LaBarre MJ, Anderson D, Reff M (2001) Expression of GnTIII in a recombinant anti-CD20 CHO production cell line: Expression of antibodies with altered glycoforms leads to an increase in ADCC through higher affinity for FC gamma RIII. Biotechnol Bioeng 74:288–294
de Godoy LM, Olsen JV, de Souza GA, Li G, Mortensen P, Mann M (2006) Status of complete proteome analysis by mass spectrometry: SILAC labeled yeast as a model system. Genome Biol 7:R50
Dinnis DM, Stansfield SH, Schlatter S, Smales CM, Alete D, Birch JR, Racher AJ, Marshall CT, Nielsen LK, James DC (2006) Functional proteomic analysis of GS-NS0 murine myeloma cell lines with varying recombinant monoclonal antibody production rate. Biotechnol Bioeng 94:830–841
Elbashir SM, Lendeckel W, Tuschl T (2001) RNA interference is mediated by 21- and 22-nucleotide RNAs. Genes Dev 15:188–200
Europa AF, Gambhir A, Fu PC, Hu WS (2000) Multiple steady states with distinct cellular metabolism in continuous culture of mammalian cells. Biotechnol Bioeng 67:25–34
Feng YQ, Seibler J, Alami R, Eisen A, Westerman KA, Leboulch P, Fiering S, Bouhassira EE (1999) Site-specific chromosomal integration in mammalian cells: highly efficient CRE recombinase-mediated cassette exchange. J Mol Biol 292:779–785
Figueroa B, Jr, Ailor E, Osborne D, Hardwick JM, Reff M, Betenbaugh MJ (2006) Enhanced cell culture performance using inducible anti-apoptotic genes E1B-19K and Aven in the production of a monoclonal antibody with Chinese hamster ovary cells. Biotechnol Bioeng 2006 Nov 10, [Epub ahead of print]
Figueroa B Jr., Chen S, Oyler GA, Hardwick JM, Betenbaugh MJ (2004) Aven and Bcl-xL enhance protection against apoptosis for mammalian cells exposed to various culture conditions. Biotechnol Bioeng 85:589–600
Figueroa B Jr., Sauerwald TM, Mastrangelo AJ, Hardwick JM, Betenbaugh MJ (2001) Comparison of Bcl-2 to a Bcl-2 deletion mutant for mammalian cells exposed to culture insults. Biotechnol Bioeng 73:211–222
Ford LP (2006) Using synthetic miRNA mimics for diverting cell fate: a possibility of miRNA-based therapeutics? Leuk Res 30:511–513
Fussenegger M, Mazur X, Bailey JE (1998a) pTRIDENT, a novel vector family for tricistronic gene expression in mammalian cells. Biotechnol Bioeng 57:1–10
Fussenegger M, Schlatter S, Datwyler D, Mazur X, Bailey JE (1998b) Controlled proliferation by multigene metabolic engineering enhances the productivity of Chinese hamster ovary cells. Nat Biotechnol 16:468–472
Fux C, Langer D, Kelm JM, Weber W, Fussenegger M (2004) New-generation multicistronic expression platform: pTRIDENT vectors containing size-optimized IRES elements enable homing endonuclease-based cistron swapping into lentiviral expression vectors. Biotechnol Bioeng 86:174–187
Gauthier ER, Piche L, Lemieux G, Lemieux R (1996) Role of bcl-X(L) in the control of apoptosis in murine myeloma cells. Cancer Res 56:1451–1456
Geserick C, Bonarius HP, Kongerslev L, Hauser H, Mueller PP (2000) Enhanced productivity during controlled proliferation of BHK cells in continuously perfused bioreactors. Biotechnol Bioeng 69:266–274
Gorg A, Weiss W, Dunn MJ (2004) Current two-dimensional electrophoresis technology for proteomics. Proteomics 4:3665–3685
Gossen M, Bujard H (1992) Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc Natl Acad Sci USA 89:5547–5551
Gupta S (2003) Molecular signaling in death receptor and mitochondrial pathways of apoptosis (Review). Int J Oncol 22:15–20
Hartenbach S, Fussenegger M (2005) Autoregulated, bidirectional and multicistronic gas-inducible mammalian as well as lentiviral expression vectors. J Biotechnol 120:83–98
Hayashi T, Ohya T, Kiyama E, Miki H, Kobayashi K, Honda Kn Omasa, Ohtake H (2006) Enhancement of AT-III production in Chinese Hamster ovary cells by modulating transcription factors activated in unfolded protein response. Presented at the 19th JAACT Meeting, Kyoto, 25–28 Sept 2006, Proceedings in press
Hayduk EJ, Choe LH, Lee KH (2004) A two-dimensional electrophoresis map of Chinese hamster ovary cell proteins based on fluorescence staining. Electrophoresis 25:2545–2556
Hayduk EJ, Lee KH (2005) Cytochalasin D can improve heterologous protein productivity in adherent Chinese hamster ovary cells. Biotechnol Bioeng 90:354–364
Holmes P, Al-Rubeai M (1999) Improved cell line development by a high throughput affinity capture surface display technique to select for high secretors. J Immunol Methods 230:141–147
Hwang HW, Mendell JT (2006) MicroRNAs in cell proliferation, cell death, and tumorigenesis. Br J Cancer 94:776–780
Ideker T, Thorsson V, Ranish JA, Christmas R, Buhler J, Eng JK, Bumgarner R, Goodlett DR, Aebersold R, Hood L (2001) Integrated genomic and proteomic analyses of a systematically perturbed metabolic network. Science 292:929–934
Ifandi V, Al-Rubeai M (2003) Stable transfection of CHO cells with the c-myc gene results in increased proliferation rates, reduces serum dependency, and induces anchorage independence. Cytotechnology 41:1–10
Ifandi V, Al-Rubeai M (2005) Regulation of cell proliferation and apoptosis in CHO-K1 cells by the coexpression of c-Myc and Bcl-2. Biotechnol Prog 21:671–677
Irani N, Beccaria AJ, Wagner R (2002) Expression of recombinant cytoplasmic yeast pyruvate carboxylase for the improvement of the production of human erythropoietin by recombinant BHK-21 cells. J Biotechnol 93:269–282
Jenkins N, Parekh RB, James DC (1996) Getting the glycosylation right: implications for the biotechnology industry. Nat Biotechnol 14:975–981
Jones D, Kroos N, Anema R, van MB, Vooys A, van der KS, van der HE, Smits S, Schouten J, Brouwer K, Lagerwerf F, van BP, Opstelten DJ, Logtenberg T, Bout A (2003) High-level expression of recombinant IgG in the human cell line per.c6. Biotechnol Prog 19:163–168
Jung D, Cote S, Drouin M, Simard C, Lemieux R (2002) Inducible expression of Bel-XL restricts apoptosis resistance to the antibody secretion phase in hybridoma cultures. Biotechnol Bioeng 79:180–187
Katterle B, Muller K, Dippel M (2006) A question of endurance. Eur Biopharmaceutical Rev Bioformulation Manufacturing 108–112
Kaufmann H, Mazur X, Fussenegger M, Bailey JE (1999) Influence of low temperature on productivity, proteome and protein phosphorylation of CHO cells. Biotechnol Bioeng 63:573–582
Khoo G, Falciani F, Al-Rubeai M (2007) A genome-wide transcriptional analysis of producer and non-producer NS0 myeloma cell lines. Biotechnol Appl Biochem 2007, Jan 16 [Epub ahead of print]
Kim SJ, Lee GM (1999) Cytogenetic analysis of chimeric antibody-producing CHO cells in the course of dihydrofolate reductase-mediated gene amplification and their stability in the absence of selective pressure. Biotechnol Bioeng 64:741–749
Kirchhoff S, Kroger A, Cruz H, Tummler M, Schaper F, Koster M, Hauser H (1996) Regulation of cell growth by IRF-1 in BHK-21 cells. Cytotechnology 22:147–156
Kirchhoff S, Schaper F, Hauser H (1993) Interferon regulatory factor 1 (IRF-1) mediates cell growth inhibition by transactivation of downstream target genes. Nucleic Acids Res 21:2881–2889
Kobata A (1992) Structures and functions of the sugar chains of glycoproteins. Eur J Biochem 209:483–501
Koester M, Kirchhoff S, Schaper F, Hauser H (1995) Proliferation control of mammalian cells by the tumor suppressor IRF-1. Cytotechnology 18:67–75
Krampe B, Al-Rubeai M (2006) Transcriptomic and proteomic analysis of antibody producing NS0 cells cultivated in a high cell density perfusion culture. Global mRNA and protein expression analysis. Meeting at the National Institute for Cellular Biotechnology, Dublin, Ireland
Kromenaker SJ, Srienc F (1994) Stability of producer hybridoma cell lines after cell sorting: a case study. Biotechnol Prog 10:299–307
Kuo WP, Liu F, Trimarchi J, Punzo C, Lombardi M, Sarang J, Whipple ME, Maysuria M, Serikawa K, Lee SY, McCrann D, Kang J, Shearstone JR, Burke J, Park DJ, Wang X, Rector TL, Ricciardi-Castagnoli P, Perrin S, Choi S, Bumgarner R, Kim JH, Short GF III, Freeman MW, Seed B, Jensen R, Church GM, Hovig E, Cepko CL, Park P, Ohno-Machado L, Jenssen TK (2006) A sequence-oriented comparison of gene expression measurements across different hybridization-based technologies. Nat Biotechnol 24:832–840
Kuystermans D, Al-Rubeai M (2006) Proteomic analysis of differential protein expression induced by c-myc over-expression in CHO cells. Global mRNA and protein expression analysis. Meeting at the National Institute for Cellular Biotechnology, Dublin, Ireland
Kwaks TH, Otte AP (2006) Employing epigenetics to augment the expression of therapeutic proteins in mammalian cells. Trends Biotechnol 24:137–142
Lasunskaia EB, Fridlianskaia II, Darieva ZA, da Silva MS, Kanashiro MM, Margulis BA (2003) Transfection of NS0 myeloma fusion partner cells with HSP70 gene results in higher hybridoma yield by improving cellular resistance to apoptosis. Biotechnol Bioeng 81:496–504
Lee KH, Harrington MG, Bailey JE (1996a) Two-dimensional electrophoresis of proteins as a tool in the metabolic engineering of cell cycle regulation. Biotechnol Bioeng 50:336–340
Lee KH, Sburlati A, Renner WA, Bailey JE (1996b) Deregulated expression of cloned transcription factor E2F-1 in Chinese hamster ovary cells shifts protein patterns and activates growth in protein-free medium. Biotechnology and Bioengineering 50:273–279
Lee MS, Kim KW, Kim YH, Lee GM (2003) Proteome analysis of antibody-expressing CHO cells in response to hyperosmotic pressure. Biotechnol Prog 19:1734–1741
Lee SK, Lee GM (2003) Development of apoptosis-resistant dihydrofolate reductase-deficient Chinese hamster ovary cell line. Biotechnol Bioeng 82:872–876
Li JH, Huang Z, Sun XM, Yang PY, Zhang YX (2006) Understanding the enhanced effect of dimethyl sulfoxide on hepatitis B surface antigen expression in the culture of Chinese hamster ovary cells on the basis of proteome analysis. Enzyme Microbial Technol 38:372–380
Lilley KS, Friedman DB (2004) All about DIGE: quantification technology for differential-display 2D-gel proteomics. Expert Rev Proteomics 1:401–409
Lim SF, Chuan KH, Liu S, Loh SO, Chung BY, Ong CC, Song Z (2006) RNAi suppression of Bax and Bak enhances viability in fed-batch cultures of CHO cells. Metab Eng 8:509–522
Lucas BK, Giere LM, DeMarco RA, Shen A, Chisholm V, Crowley CW (1996) High-level production of recombinant proteins in CHO cells using a dicistronic DHFR intron expression vector. Nucleic Acids Res 24:1774–1779
Mastrangelo AJ, Hardwick JM, Bex F, Betenbaugh MJ (2000) Part I. Bcl-2 and Bcl-x(L) limit apoptosis upon infection with alphavirus vectors Biotechnol Bioeng 67:544–554
Mazur X, Fussenegger M, Renner WA, Bailey JE (1998) Higher productivity of growth-arrested Chinese hamster ovary cells expressing the cyclin-dependent kinase inhibitor p27. Biotechnol Prog 14:705–713
Meents H, Enenkel B, Eppenberger HM, Werner RG, Fussenegger M (2002) Impact of coexpression and coamplification of sICAM and antiapoptosis determinants bcl-2/bcl-x(L) on productivity, cell survival, and mitochondria number in CHO-DG44 grown in suspension and serum-free media. Biotechnol Bioeng 80:706–716
Mercille S, Massie B (1999) Apoptosis-resistant E1B-19K-expressing NS/0 myeloma cells exhibit increased viability and chimeric antibody productivity under perfusion culture conditions. Biotechnol Bioeng 63:529–543
Milbrandt JD, Azizkhan JC, Hamlin JL (1983) Amplification of a cloned Chinese hamster dihydrofolate reductase gene after transfer into a dihydrofolate reductase-deficient cell line. Mol Cell Biol 3:1274–1282
Miller I, Crawford J, Gianazza E (2006) Protein stains for proteomic applications: which, when, why? Proteomics 6:5385–5408
Mori K, Kuni-Kamochi R, Yamane-Ohnuki N, Wakitani M, Yamano K, Imai H, Kanda Y, Niwa R, Iida S, Uchida K, Shitara K, Satoh M (2004) Engineering Chinese hamster ovary cells to maximize effector function of produced antibodies using FUT8 siRNA. Biotechnol Bioeng 88:901–908
Natsume A, Wakitani M, Yamane-Ohnuki N, Shoji-Hosaka E, Niwa R, Uchida K, Satoh M, Shitara K (2006) Fucose removal from complex-type oligosaccharide enhances the antibody-dependent cellular cytotoxicity of single-gene-encoded bispecific antibody comprising of two single-chain antibodies linked to the antibody constant region. J Biochem (Tokyo) 140:359–368
Ong SE, Mann M (2005) Mass spectrometry-based proteomics turns quantitative. Nat Chem Biol 1:252–262
Passini CA, Goochee CF (1989) Response of a mouse hybridoma cell-line to heat-shock, agitation, and sparging. Biotechnol Prog 5:175–188
Patel TP, Parekh RB, Moellering BJ, Prior CP (1992) Different culture methods lead to differences in glycosylation of a murine IgG monoclonal antibody. Biochem J 285(Pt 3):839–845
Perani A, Singh RP, Chauhan R, Al-Rubeai M (1998) Variable functions of bcl-2 in mediating bioreactor stress-induced apoptosis in hybridoma cells. Cytotechnology 28:177–188
Plasterk RH (2006) Micro RNAs in animal development. Cell 124:877–881
Rabinder PS (1996) Enhancement of survivability of mammalian cells by overexpression of the apoptosis-suppressor gene bcl-2. Biotechnol Bioeng 52:166–175
Racher AJ (2004) GS Gene Expression System: GS, biochemical comparability, and cell line stability. Waterside Workshop Presentation Slide, 1–9–2004. Lonza Biologics. (http://www.lonza.com/group/en/company/news/tradefairs). Ref Type: Slide
Racher AJ (2006) FACS-based method for shortening cell line selection timelines: direct comparison with a conventional approach. Cell Culture Engineering X. Whistler, BC, Canada, 23–4–2006. Engineering Conferences International, 99. Ref Type: Conference Proceeding
Raju TS, Briggs JB, Borge SM, Jones AJ (2000) Species-specific variation in glycosylation of IgG: evidence for the species-specific sialylation and branch-specific galactosylation and importance for engineering recombinant glycoprotein therapeutics. Glycobiology 10:477–486
Raju TS, Briggs JB, Chamow SM, Winkler ME, Jones AJ (2001) Glycoengineering of therapeutic glycoproteins: in vitro galactosylation and sialylation of glycoproteins with terminal N-acetylglucosamine and galactose residues. Biochemistry 40:8868–8876
Roe MR, Griffin TJ (2006) Gel-free mass spectrometry-based high throughput proteomics: Tools for studying biological response of proteins and proteomes. Proteomics 6:4678–4687
Sauerwald TM, Betenbaugh MJ, Oyler GA (2002) Inhibiting apoptosis in mammalian cell culture using the caspase inhibitor XIAP and deletion mutants. Biotechnol Bioeng 77:704–716
Sauerwald TM, Oyler GA, Betenbaugh MJ (2003) Study of caspase inhibitors for limiting death in mammalian cell culture. Biotechnol Bioeng 81:329–340
Scallon BJ, Tam SH, McCarthy SG, Cai AN, Raju TS (2006) Higher levels of sialylated Fc glycans in immunoglobulin G molecules can adversely impact functionality. Mol Immunol 44:1524–1534
Schena M, Shalon D, Davis RW, Brown PO (1995) Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science 270:467–470
Seow TK, Korke R, Liang RC, Ong SE, Ou K, Wong K, Hu WS, Chung MC (2001) Proteomic investigation of metabolic shift in mammalian cell culture. Biotechnol Prog 17:1137–1144
Seth G, Hossler P, Yee JC, Hu WS (2006a) Engineering cells for cell culture bioprocessing–physiological fundamentals. Adv Biochem Eng Biotechnol 101:119–164
Seth G, Ozturk M, Hu WS (2006b) Reverting cholesterol auxotrophy of NS0 cells by altering epigenetic gene silencing. Biotechnol Bioeng 93:820–827
Seth G, Philp RJ, Denoya CD, McGrath K, Stutzman-Engwall KJ, Yap M, Hu WS (2005) Large-scale gene expression analysis of cholesterol dependence in NS0 cells. Biotechnol Bioeng 90:552–567
Shen D, Sharfstein ST (2005) Genome-wide analysis of the transcriptional response of murine hybridomas to osmotic shock. Biotechnol Bioeng 93:132–145
Shields RL, Lai J, Keck R, O’Connell LY, Hong K, Meng YG, Weikert SH, Presta LG (2002) Lack of fucose on human IgG1 N-linked oligosaccharide improves binding to human Fcgamma RIII and antibody-dependent cellular toxicity. J Biol Chem 277:26733–26740
Shinkawa T, Nakamura K, Yamane N, Shoji-Hosaka E, Kanda Y, Sakurada M, Uchida K, Anazawa H, Satoh M, Yamasaki M, Hanai N, Shitara K (2003) The absence of fucose but not the presence of galactose or bisecting N-acetylglucosamine of human IgG1 complex-type oligosaccharides shows the critical role of enhancing antibody-dependent cellular cytotoxicity. J Biol Chem 278:3466–3473
Simpson HS, Milner AE, Al-Rubeai M (1997) Prevention of hybridoma cell death by bcl-2 during suboptimal culture conditions. Biotechnol Bioeng 54:1–16
Simpson NH, Singh RP, Perani A, Goldenzon C, Al-Rubeai M (1998) In hybridoma cultures, deprivation of any single amino acid leads to apoptotic death, which is suppressed by the expression of the bcl-2 gene. Biotechnol Bioeng 59:90–98
Sinclair AM, Elliott S (2005) Glycoengineering: the effect of glycosylation on the properties of therapeutic proteins. J Pharm Sci 94:1626–1635
Singh RP, Emery AN, Al-Rubeai M (1996) Enhancement of survivability of mammalian cells by overexpression of the apoptosis-suppressor gene bel-2. Biotechnol Bioeng 52:166–175
Smales CM, Birch JR, Racher AJ, Marshall CT, James DC (2003) Evaluation of individual protein errors in silver-stained two-dimensional gels. Biochem Biophys Res Commun 306:1050–1055
Smales CM, Dinnis DM, Stansfield SH, Alete D, Sage EA, Birch JR, Racher AJ, Marshall CT, James DC (2004) Comparative proteomic analysis of GS-NS0 murine myeloma cell lines with varying recombinant monoclonal antibody production rate. Biotechnol Bioeng 88:474–488
Swiderek H, Al-Rubeai M (2006) Functional Genome-Wide Analysis of Antibody Producing NS0 Cell Line Cultivated at Different Temperatures. Biotechnol Bioeng (in press)
Terada S, Fukuoka K, Fujita T, Komatsu T, Takayama S, Reed JC, Suzuki E (1997) Anti-apoptotic genes, bag-1 and bel-2, enabled hybridoma cells to survive under treatment for arresting cell cycle. Cytotechnology 25:17–23
Tey BT, Al-Rubeai M (2004) Suppression of apoptosis in perfusion culture of Myeloma NS0 cells enhances cell growth but reduces antibody productivity. Apoptosis 9:843–852
Tey BT, Singh RP, Piredda L, Piacentini M, Al-Rubeai M (2000a) Influence of bcl-2 on cell death during the cultivation of a Chinese hamster ovary cell line expressing a chimeric antibody. Biotechnol Bioeng 68:31–43
Tey BT, Singh RP, Piredda L, Piacentini M, Al-Rubeai M (2000b) Bcl-2 mediated suppression of apoptosis in myeloma NS0 cultures. J Biotechnol 79:147–159
Tian Q, Stepaniants SB, Mao M, Weng L, Feetham MC, Doyle MJ, Yi EC, Dai H, Thorsson V, Eng J, Goodlett D, Berger JP, Gunter B, Linseley PS, Stoughton RB, Aebersold R, Collins SJ, Hanlon WA, Hood LE (2004) Integrated genomic and proteomic analyses of gene expression in Mammalian cells. Mol Cell Proteomics 3:960–969
Tigges M, Fussenegger M (2006) Xbp1-based engineering of secretory capacity enhances the productivity of Chinese hamster ovary cells. Metab Eng 2006, Apr 3 [Epub ahead of print]
Trish B, Tim C, Michele M, Brian F, David K, Robert C, Thomas CT, Christopher B (2002) The use of UCOE vectors in combination with a preadapted serum free, suspension cell line allows for rapid production of large quantities of protein. Cytotechnology V38:43–46
Umaña P, Jean-Mairet J, Moudry R, Amstutz H, Bailey JE (1999) Engineered glycoforms of an antineuroblastoma IgG1 with optimized antibody-dependent cellular cytotoxic activity. Nat Biotechnol 17:176–180
Van Dyk DD, Misztal DR, Wilkins MR, Mackintosh JA, Poljak A, Varnai JC, Teber E, Walsh BJ, Gray PP (2003) Identification of cellular changes associated with increased production of human growth hormone in a recombinant Chinese hamster ovary cell line. Proteomics 3:147–156
Varki A (1998) Factors controlling the glycosylation potential of the Golgi apparatus. Trends Cell Biol 8:34–40
Veraitch FS, Al-Rubeai M (2005) Enhanced growth in NS0 cells expressing aminoglycoside phosphotransferase is associated with changes in metabolism, productivity, and apoptosis. Biotechnol Bioeng 92:589–599
Walsh G (2006) Biopharmaceutical benchmarks 2006. Nat Biotechnol 24:769–776
Walsh G, Jefferis R (2006) Post-translational modifications in the context of therapeutic proteins. Nat Biotechnol 24:1241–1252
Warner TG (1999) Enhancing therapeutic glycoprotein production in Chinese hamster ovary cells by metabolic engineering endogenous gene control with antisense DNA and gene targeting. Glycobiology 9:841–850
Watanabe S, Shuttleworth J, Al-Rubeai M (2002) Regulation of cell cycle and productivity in NS0 cells by the over-expression of p21CIP1. Biotechnol Bioeng 77:1–7
Weber W, Marty RR, Keller B, Rimann M, Kramer BP, Fussenegger M (2002) Versatile macrolide-responsive mammalian expression vectors for multiregulated multigene metabolic engineering. Biotechnol Bioeng 80:691–705
Weber W, Rimann M, de Glutz FN, Weber E, Memmert K, Fussenegger M (2005a) Gas-inducible product gene expression in bioreactors. Metab Eng 7:174–181
Weber W, Rimann M, Spielmann M, Keller B, oud-El BM, Aubel D, Weber CC, Fussenegger M (2004) Gas-inducible transgene expression in mammalian cells and mice. Nat Biotechnol 22:1440–1444
Weber W, Spielmann M, oud El-Baba M, Keller B, Aubel D, Fussenegger M (2005b) Tobacco smoke as inducer for gas phase-controlled transgene expression in mammalian cells and mice. Biotechnol Bioeng 90:893–897
Weikert S, Papac D, Briggs J, Cowfer D, Tom S, Gawlitzek M, Lofgren J, Mehta S, Chisholm V, Modi N, Eppler S, Carroll K, Chamow S, Peers D, Berman P, Krummen L (1999) Engineering Chinese hamster ovary cells to maximize sialic acid content of recombinant glycoproteins. Nat Biotechnol 17:1116–1121
Werner NS, Weber W, Fussenegger M, and Geisse S (2006) A gas-inducible expression system in HEK.EBNA cells applied to controlled proliferation studies by expression of p27(Kip1). Biotechnol Bioeng 2006, Oct 20 [Epub ahead of print]
Willey KP (1999) An elusive role for glycosylation in the structure and function of reproductive hormones. Hum Reprod Update 5:330–355
Williams S, Mustoe T, Mulcahy T, Griffiths M, Simpson D, Antoniou M, Irvine A, Mountain A, Crombie R (2005) CpG-island fragments from the HNRPA2B1/CBX3 genomic locus reduce silencing and enhance transgene expression from the hCMV promoter/enhancer in mammalian cells. BMC Biotechnol 5:17
Wong DC, Wong KT, Lee YY, Morin PN, Heng CK, Yap MG (2006a) Transcriptional profiling of apoptotic pathways in batch and fed-batch CHO cell cultures. Biotechnol Bioeng 94:373–382
Wong DC, Wong KT, Nissom PM, Heng CK, Yap MG (2006b) Targeting early apoptotic genes in batch and fed-batch CHO cell cultures. Biotechnol Bioeng 95:350–361
Wong VV, Nissom PM, Sim SL, Yeo JH, Chuah SH, Yap MG (2006c) Zinc as an insulin replacement in hybridoma cultures. Biotechnol Bioeng 93:553–563
Wurm FM (2004) Production of recombinant protein therapeutics in cultivated mammalian cells. Nat Biotechnol 22:1393–1398
Wyss DF, Wagner G (1996) The structural role of sugars in glycoproteins. Curr Opin Biotechnol 7:409–416
Yang M, Butler M (2000a) Effect of ammonia on the glycosylation of human recombinant erythropoietin in culture. Biotechnol Prog 16:751–759
Yang M, Butler M (2000b) Effects of ammonia on CHO cell growth, erythropoietin production, and glycosylation. Biotechnol Bioeng 68:370–380
Yano H, Takagi Y, Cao Y, Omasa T, Asakawa S, Shimizu N, Ohtake H (2006) Analysis of specific chromosomal region in Chinese Hamster ovary-dihydrofolate reductase gene amplification. Presented at the 19th JAACT Meeting, Kyoto 25–28 Sept 2006, Proceedings in press
Yohito Itoh, Hiroshi Ueda, Eiji Suzuki (1995) Overexpression of bcl-2, apoptosis suppressing gene: Prolonged viable culture period of hybridoma and enhanced antibody production. Biotechnol Bioeng 48:118–122
Yoon SK, Hwang SO, Lee GM (2004) Enhancing effect of low culture temperature on specific antibody productivity of recombinant Chinese hamster ovary cells: clonal variation. Biotechnol Prog 20:1683–1688
Yoshida H, Oku M, Suzuki M, Mori K (2006) pXBP1(U) encoded in XBP1 pre-mRNA negatively regulates unfolded protein response activator pXBP1(S) in mammalian ER stress response. J Cell Biol 172:565–575
Yoshikawa T, Nakanishi F, Ogura Y, Oi D, Omasa T, Katakura Y, Kishimoto M, Suga K (2000) Amplified gene location in chromosomal DNA affected recombinant protein production and stability of amplified genes. Biotechnol Prog 16:710–715
Acknowledgement
This work is funded by Science Foundation Ireland (SFI).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kuystermans, D., Krampe, B., Swiderek, H. et al. Using cell engineering and omic tools for the improvement of cell culture processes. Cytotechnology 53, 3–22 (2007). https://doi.org/10.1007/s10616-007-9055-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10616-007-9055-6